AGN Allergan Inc.

NOTICE TO ALLERGAN CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investigates the Allergan Savings and Investment Plan for Possible ERISA Violations

Zamansky LLC announces that it has commenced an investigation of Allergan plc (NYSE: AGN)(“Allergan”) on behalf of its current and former employees over the Allergan Savings and Investment Plan (the “Plan”) for potential violations of the federal Employee Retirement Income Security Act (“ERISA”). ERISA imposes fiduciary duties to prudently manage and invest plan assets. We are investigating whether these duties were violated by the continued offering of Allergan stock from June 15, 2015 through November 3, 2016 as an investment option for employees under the Plan.

On November 4, 2016, a securities class action lawsuit was filed against Allergan, Actavis and certain officers, following news of an investigation by the U.S. Department of Justice for alleged violation of federal antitrust laws. The lawsuit alleges that Allergan colluded with Actavis plc which it acquired in 2015, and other competitors, to fix the prices of various generic drugs, and that it misled investors about its alleged activities. The lawsuit alleges that Allergan’s stock was artificially inflated due to the alleged price collusion, and that it corrected as the truth slowly came out.

According to employee stock and investment fraud attorney, Jake Zamansky, current or former Allergan employees who purchased and held Allergan stock through the Plan from June 2015 through November 2016 may have had their retirement savings damaged. The allegations about Allergan’s antitrust investigation raise serious issues whether the Plan’s fiduciaries properly executed their duties under ERISA, he states. ERISA is designed to protect employees’ retirement savings from imprudent and inappropriate investments, Zamansky states.

What Current and Former Allergan Employees Can Do

If you are an existing or former Allergan employee who purchased and held Allergan stock from June 2015 through November 2016 through the Allergan Savings and Investment Plan, please contact our firm for an evaluation of your rights. You can contact Jake Zamansky by telephone at (212) 742-1414 or by email at [email protected].

About Zamansky LLC

Zamansky LLC is a leading stock law firm specializing in securities fraud, ERISA and employment class actions. We are investment fraud attorneys who represent both individual and institutional investors. Our practice is nationally recognized for our ability to aggressively prosecute cases and recover investment losses.

To learn more about Zamansky LLC, please visit our website, http://www.zamansky.com.

EN
18/11/2016

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Allergan Inc.

Jonathan Moreland
  • Jonathan Moreland

Weekly Insider Tables: Mar 24, 2018

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses I...

STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Southern District of New York on behalf of purchasers of Allergan plc (NYSE: AGN) (“Allergan” or the “Company”) securities during the period between February 25, 2014 and November 2, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until January 3, 2017 to seek a...

 PRESS RELEASE

NOTICE TO ALLERGAN CURRENT AND FORMER EMPLOYEES: Zamansky LLC Investig...

NEW YORK--(BUSINESS WIRE)-- Zamansky LLC announces that it has commenced an investigation of Allergan plc (NYSE: AGN)(“Allergan”) on behalf of its current and former employees over the Allergan Savings and Investment Plan (the “Plan”) for potential violations of the federal Employee Retirement Income Security Act (“ERISA”). ERISA imposes fiduciary duties to prudently manage and invest plan assets. We are investigating whether these duties were violated by the continued offering of Allergan stock from June 15, 2015 through November 3, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch